武田薬品工業
In January 2016, after six months of negotiations, the company agreed to be acquired by Shire for $32 billion. The deal was completed on 3 June 2016. Subsequently, Shire was acquired by Takeda Pharmaceutical Company for $62 billion in January 2019.